{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T19:11:51Z","timestamp":1720206711408},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Union and the State of Hungary"},{"DOI":"10.13039\/501100004895","name":"European Social Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["GINOP 2.3.2-15-2016-00022"],"award-info":[{"award-number":["GINOP 2.3.2-15-2016-00022"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.toxlet.2017.09.005","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T04:17:39Z","timestamp":1505276259000},"page":"44-52","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Toxicology studies of primycin-sulphate using a three-dimensional (3D) in vitro human liver aggregate model"],"prefix":"10.1016","volume":"281","author":[{"given":"\u00c1gota","family":"P\u00e9nzes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elhusseiny Mohamed","family":"Mahmud Abdelwahab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsanett A.","family":"P\u00e9teri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit","family":"Bov\u00e1ri-Biri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba","family":"Fekete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"Miskei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kriszti\u00e1n","family":"Kvell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit E.","family":"Pongr\u00e1cz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2017.09.005_bib0005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000137372","article-title":"Acetylcholine-releasing effect of primycin, a highly active antibiotic","volume":"20","author":"Ad\u00e1m-Vizi","year":"1980","journal-title":"Pharmacology"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0887-2333(99)00007-7","article-title":"Expression of cytochromes P-450 2E1, 3A4 and 1A1\/1A2 in growing and confluent human HepG2 hepatoma cells-effect of ethanol","volume":"13","author":"Alexandre","year":"1999","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0015","first-page":"140","article-title":"Favourable observations with Ebrimycin gel in the outpatient department of surgery","volume":"35","author":"B\u00e1lint","year":"1987","journal-title":"Ther. Hung."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0020","first-page":"136","article-title":"Ebrimycin gel in the treatment of pyodermas and bacterial secondary infections","volume":"35","author":"B\u00edr\u00f3","year":"1987","journal-title":"Ther. Hung."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0025","doi-asserted-by":"crossref","first-page":"32852","DOI":"10.1074\/jbc.M305361200","article-title":"Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme","volume":"278","author":"Barbier","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0035","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1096\/fasebj.13.14.1883","article-title":"Effect of cell\u2013cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells","volume":"13","author":"Bhatia","year":"1999","journal-title":"FASEB J."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0040","first-page":"625","article-title":"The mode of action of some antibiotics on red blood cell membranes","volume":"5","author":"Blask\u00f3","year":"1986","journal-title":"Gen. Physiol. Biophys."},{"issue":"5\/6","key":"10.1016\/j.toxlet.2017.09.005_bib0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drudis.2012.10.003","article-title":"Three-dimensional cell culture: the missing link in drug discovery","volume":"18","author":"Breslin","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0050","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/bcp.12497","article-title":"Systemic exposure of topical erythromycin in comparison to oral administration and the effect on cytochrome P450 3A4 activity","volume":"78","author":"Carls","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0055","doi-asserted-by":"crossref","first-page":"674","DOI":"10.18632\/aging.100064","article-title":"CXCL5 drives obesity to diabetes, and further","volume":"1","author":"Chavey","year":"2009","journal-title":"Aging (Albany, NY)"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/00498250802613620","article-title":"Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells","volume":"39","author":"Choi","year":"2009","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0065","series-title":"Cytokeratins of the Liver and Intestine Epithelial Cells During Development and Disease. Cytokeratins ? Tools in Oncology","author":"Chougule","year":"2012"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0070","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11886-009-0067-z","article-title":"Low-density lipoprotein and apolipoprotein B: clinical use in patients with coronary heart disease","volume":"11","author":"Cromwell","year":"2009","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/01.jcp.0000104908.75206.26","article-title":"Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers","volume":"24","author":"DeVane","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0080","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/me.2009-0265","article-title":"Serum- and glucocorticoid-inducible kinase 1 (SGK1) regulates adipocyte differentiation via forkhead box O1","volume":"24","author":"Di Pietro","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jps.22257","article-title":"A review of three-dimensional in vitro tissue models for drug discovery and transport studies","volume":"100","author":"Elliott","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0090","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/jpet.104.075416","article-title":"Mechanism-based inactivation of CYP3A by HIV protease inhibitors","volume":"312","author":"Ernest","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0095","unstructured":"FDA, 2011. No Title [WWW Document], Drug Dev. Drug Interact. Table Substrates, Inhib. Inducers."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0100","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ijmm.2014.08.001","article-title":"Re-evaluation of in vitro activity of primycin against prevalent multiresistant bacteria","volume":"304","author":"Feiszt","year":"2014","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1556\/030.64.2017.002","article-title":"Effect of primycin on growth-arrested cultures and cell integrity of Staphylococcus aureus","volume":"64","author":"Feiszt","year":"2017","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7555\/JBR.28.20140019","article-title":"Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion","volume":"28","author":"Fisher","year":"2014","journal-title":"J. Biomed. Res."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/1389200043335414","article-title":"Human hepatocytes in primary culture: the choice to investigate drug metabolism in man","volume":"5","author":"G\u00f3mez-Lech\u00f3n","year":"2004","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cbi.2006.10.013","article-title":"Hepatocytes\u2013the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo","volume":"168","author":"G\u00f3mez-Lech\u00f3n","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1134\/S1990519X07020058","article-title":"Expression of different liver cell markers during the early prenatal human development","volume":"1","author":"Gumerova","year":"2007","journal-title":"Cell Tissue Biol."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/00498250310001657568","article-title":"Phase I and II enzyme characterization of two sources of HepG2 cell lines","volume":"34","author":"Hewitt","year":"2004","journal-title":"Xenobiotica"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00689977","article-title":"The mode of action of primycin","volume":"121","author":"Horv\u00e1th","year":"1979","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0045-6039(80)90026-3","article-title":"Differentiation of the mouse hepatic primordium. I. An analysis of tissue interactions in hepatocyte differentiation","volume":"9","author":"Houssaint","year":"1980","journal-title":"Cell Differ."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0145","first-page":"577","article-title":"Functional analyses of albumin expression in a series of hepatocyte cell lines and in primary hepatocytes","volume":"3","author":"Hu","year":"1992","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.cytogfr.2015.07.015","article-title":"Emerging roles for IL-11 signaling in cancer development and progression: focus on breast cancer","volume":"26\/5","author":"Johnstone","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejpb.2005.05.009","article-title":"Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation","volume":"62","author":"Keck","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","article-title":"Nanosizing\u2013oral formulation development and biopharmaceutical evaluation","volume":"59","author":"Kesisoglou","year":"2007","journal-title":"Adv. Drug Deliv. Rev"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0165","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nbt1361","article-title":"2008. Microscale culture of human liver cells for drug development","volume":"26","author":"Khetani","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0170","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.metabol.2011.06.014","article-title":"Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus","volume":"61","author":"Kulkarni","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0175","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7164\/antibiotics.32.161","article-title":"Effect of primycin on the inner membrane permeability of rat liver mitochondria","volume":"32","author":"M\u00e9sz\u00e1ros","year":"1979","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0180","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1016\/j.biomaterials.2014.03.020","article-title":"Differentiation of liver progenitor cell line to functional organotypic cultures in 3D nanofibrillar cellulose and hyaluronan-gelatin hydrogels","volume":"35","author":"Malinen","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jmhi.2014.05.002","article-title":"IL-24: A novel gene therapy candidate for immune system upregulation in Hodgkin\u2019s lymphoma","volume":"9\/1","author":"Manesh","year":"2015","journal-title":"J. Med. Hypotheses Ideas"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0190","unstructured":"N\u00f3gr\u00e1di, M., 1988. Primycin (Ebrimycin\u00ae) \u2013 a new topical antibiotic, 24, 563\u2013566."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0195","series-title":"Hepatocyte Cytodifferentiation and Cell-to-cell Communication","first-page":"71","author":"Olson","year":"1990"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0200","first-page":"125","article-title":"Experiences in the Ebrimycin gel treatment of burns","volume":"38","author":"Papp","year":"1990","journal-title":"Ther. Hung."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0205","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejmech.2017.06.006","article-title":"Anti-diabetic activity of fused PPAR\u03b3-SIRT1 ligands with limited body-weight gain by mimicking calorie restriction and decreasing SGK1 expression","volume":"137","author":"Pirat","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0210","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/107632703322066589","article-title":"Long-term culture of functional liver tissue: three-dimensional coculture of primary hepatocytes and stellate cells","volume":"9","author":"Riccalton-Banks","year":"2003","journal-title":"Tissue Eng."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11745-016-4155-8","article-title":"Fatty acid binding protein-1 (FABP1) and the human FABP1 T94A variant: roles in the endocannabinoid system and dyslipidemias","volume":"51","author":"Schroeder","year":"2016","journal-title":"Lipids"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0220","doi-asserted-by":"crossref","first-page":"18422","DOI":"10.1073\/pnas.1010693107","article-title":"Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir","volume":"107","author":"Sevrioukova","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0225","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mce.2010.05.019","article-title":"Peroxisome proliferator activated receptor \u03b1 (PPAR\u03b1) and PPAR gamma coactivator (PGC-1\u03b1) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements","volume":"325","author":"Song","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0230","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.it.2007.09.003","article-title":"Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms","volume":"28","author":"Straus","year":"2007","journal-title":"Trends Immunol."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0235","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000091096","article-title":"The effect of three-dimensional co-culture of hepatocytes and hepatic stellate cells on key hepatocyte functions in vitro","volume":"181","author":"Thomas","year":"2005","journal-title":"Cells. Tissues Organs"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0240","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.7164\/antibiotics.32.1207","article-title":"Crystallization and antifungal activity of primycin","volume":"32","author":"Uri","year":"1979","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0245","first-page":"141","article-title":"Antibacterial activity of primycin against multiple strains of gram-positive bacteria","volume":"33","author":"Uri","year":"1986","journal-title":"Acta Microbiol. Hung."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0250","first-page":"466","article-title":"The toxicology and pharmacology of primycin","volume":"124","author":"Valyi-Nagy","year":"1960","journal-title":"Arch. Int. Pharmacodyn. Th\u00e9r."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0255","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/1741105b0","article-title":"Primycin, a new antibiotic","volume":"174","author":"Valyi-Nagy","year":"1954","journal-title":"Nature"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0260","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/dmd.115.067744","article-title":"Evaluation of ketoconazole and its alternative clinical CYP3A4\/5 inhibitors as inhibitors of drug transporters: the In vitro effects of ketoconazole, ritonavir, clarithromycin, and itraconazole on 13 clinically-Relevant drug transporters","volume":"44","author":"Vermeer","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0265","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/ja.2011.140","article-title":"Complex formation between primycin and ergosterol: entropy\u2013driven initiation of modification of the fungal plasma membrane structure","volume":"65","author":"Vir\u00e1g","year":"2012","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.toxlet.2017.09.005_bib0270","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/ja.2009.130","article-title":"Competitive hydrogen bonds associated with the effect of primycin antibiotic on oleic acid as a building block of plasma membranes","volume":"63","author":"Virag","year":"2010","journal-title":"J. Antibiot."},{"key":"10.1016\/j.toxlet.2017.09.005_bib0275","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/138920008784220664","article-title":"Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4","volume":"9","author":"Zhou","year":"2008","journal-title":"Curr. Drug Metab."}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427417313371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427417313371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T19:22:53Z","timestamp":1692991373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427417313371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":55,"alternative-id":["S0378427417313371"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2017.09.005","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxicology studies of primycin-sulphate using a three-dimensional (3D) in vitro human liver aggregate model","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2017.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}